Celldex Therapeutics Other Current Assets

Celldex Therapeutics (CLDX) currently reports a other current assets of $7.1M as of June 2026. That compares with $18M in the prior-year period — down 60.4% year over year. Use the charts on this page to explore Celldex Therapeutics's other current assets history and peer comparisons.

Celldex Therapeutics's other current assets decreased from $18M to $7.1M — a 60.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Celldex Therapeutics reported $7.1M in other current assets as of June 2026. That compares with $18M in the prior-year period — down 60.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $7.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Celldex Therapeutics, and consider following CLDX for alerts when major investors trade the stock.

Celldex Therapeutics is classified in the Healthcare sector. On other current assets, it currently shows $7.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLDX with unrelated industries.